Personalized approach using wearable technology for early detection of Atrial Fibrillatio
Recruiting
- Conditions
- Atrial fibrillation
- Registration Number
- NL-OMON22716
- Lead Sponsor
- Amsterdam University Medical Center, location AMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 930
Inclusion Criteria
A subject must be at least 65 years old with a CHA2DS2VASc score of = 3 for men or = 4 for women
Exclusion Criteria
Previously documented AF, patients with a pacemaker or ICD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Difference in detection of new AF between the intervention and control practices during the entire 3-year study period. (intention to screen analysis)
- Secondary Outcome Measures
Name Time Method 1.Difference in detection of new AF between the screened patients in the intervention practices and the control practices. (per protocol analysis)<br>2.Difference in time to diagnosis of AF between intervention and control practices. <br>3. Difference in other relevant cardiovascular outcomes like ischemic stroke, TIA, heart failure, dementia and the use of anticoagulation.<br>4.Difference in detection of new AF in control practices participating in the trial versus detection of AF in non-participating general practices in the network (i.e. the Hawthorne effect).<br>5.Patient experience with the monitoring device.<br>